Home Contact Shopping Video

Archive for August, 2022

Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol

Wednesday, August 31st, 2022 Posted in Cannabinoid Research | Comments Off on Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol

Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol Cannabis and Cannabinoid Research, Ahead of Print. [gallery link="file" columns="3"] Go to SourcePowered ... Read more..

A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome

Wednesday, August 31st, 2022 Posted in Cannabinoid Research | Comments Off on A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome

A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome Cannabis and Cannabinoid Research, Ahead of Print. [gallery link="file" columns="3"] Go to SourcePowered by WPeMatico Read more..

Cannabis legalization boosts use by double digits

Monday, August 29th, 2022 Posted in Science Daily | No Comments »

Cannabis legalization boosts use by double digits A new first-of-its-kind study of twins finds that residents of states where recreational marijuana is legal use it 24% more frequently than those in ... Read more..

Lessons From a Cannabis Farmer

Friday, August 26th, 2022 Posted in New York Times | No Comments »

Lessons From a Cannabis Farmer Rainforest music, Willie Nelson, subterranean greenhouses: A cannabis farmer shares trade secrets. [gallery link="file" columns="3"] Go to SourcePowered by WPeMatico Read more..

Retail Marijuana in New York: Where the Goliaths Bolster the Davids

Thursday, August 25th, 2022 Posted in New York Times | No Comments »

Retail Marijuana in New York: Where the Goliaths Bolster the Davids Medical marijuana companies are required to assist small retailers. Also, why you will continue to swelter on the subway platform. [gallery ... Read more..

N.Y. Medical Marijuana Giants Struggle to Break Into Recreational Market

Thursday, August 25th, 2022 Posted in New York Times | No Comments »

N.Y. Medical Marijuana Giants Struggle to Break Into Recreational Market Large operators want in on the state’s new retail industry. A potential multimillion-dollar fee stands in the way. [gallery link="file" columns="3"] Go to ... Read more..

Marijuana and Psychedelics Use Soars Among Young Adults, Study Finds

Tuesday, August 23rd, 2022 Posted in New York Times | No Comments »

Marijuana and Psychedelics Use Soars Among Young Adults, Study Finds The annual U.S. survey of substance use captures the growing mainstream acceptance of cannabis and hallucinogenic compounds. [gallery link="file" columns="3"] Go to SourcePowered ... Read more..

People who use therapeutic cannabis are more likely to use nicotine, too

Tuesday, August 23rd, 2022 Posted in Science Daily | No Comments »

People who use therapeutic cannabis are more likely to use nicotine, too People who use therapeutic cannabis are more likely to also use nicotine products than the general population, according to ... Read more..

Distinctive Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis

Monday, August 22nd, 2022 Posted in Cannabinoid Research | Comments Off on Distinctive Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis

Distinctive Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis Cannabis and Cannabinoid Research, Ahead of Print. [gallery link="file" columns="3"] Go to SourcePowered by WPeMatico Read more..

Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis

Saturday, August 20th, 2022 Posted in Cannabinoid Research | Comments Off on Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis

Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis Cannabis and Cannabinoid Research, Ahead of Print. [gallery link="file" columns="3"] Go ... Read more..